GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ACRS · Mar 31, 2026

Aclaris Therapeutics, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001104659-26-057202General Corporate
Capex intensity38thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.65% · OPTIONAL · VALID

Operating cash generation0thOwn-history percentile · N=8
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-909.27% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

37.18% · CORE · NOT_ENOUGH_HISTORY

Operating margin13thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.operating_margin

-1111.82% · CORE · VALID

R&D intensity88thOwn-history percentile · N=8
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

784.42% · OPTIONAL · VALID

SBC intensity75thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

160.22% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History6 statesHistory building
Period transition

What moved in the state?

Capex Intensity Decreased
Previous
1.42%
Current
0.65%
Delta
-0.77%
Cash Generation Decreased
Previous
-602.01%
Current
-909.27%
Delta
-307.26%
Growth Increased
Previous
-58.19%
Current
37.18%
Delta
95.38%
Profitability Decreased
Previous
-975.91%
Current
-1111.82%
Delta
-135.91%
R And D Intensity Increased
Previous
672.69%
Current
784.42%
Delta
111.73%
Sbc Intensity Increased
Previous
158.24%
Current
160.22%
Delta
1.98%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.